Insulet Newsroom

J.P. Morgan Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $330

Moomoo News07:31 ET

Morgan Stanley Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $317

Moomoo News05:32 ET

Insulet's Strong International Performance and Optimistic Type 2 Diabetes Market Outlook Drive Positive Analyst Rating

TipRanks05:28 ET

Citigroup Raises Price Target on Insulet to $310 From $283, Keeps Buy Rating

MT Newswires11:46 ET

Insulet Is Maintained at Overweight by Wells Fargo

Dow JonesDec 11 10:19 ET

Insulet Analyst Ratings

BenzingaDec 11 10:09 ET

Citi Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $310

Moomoo NewsDec 11 07:31 ET

Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $305

Moomoo NewsDec 11 07:31 ET

Wells Fargo Keeps Their Buy Rating on Insulet (PODD)

TipRanksDec 11 07:02 ET

Jefferies Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $340

Moomoo NewsDec 10 08:34 ET

Insulet (PODD) Receives a Buy From Jefferies

TipRanksDec 10 08:22 ET

Insulet Is Maintained at Buy by Canaccord Genuity

Dow JonesDec 9 12:40 ET

Insulet Analyst Ratings

BenzingaDec 9 12:31 ET

CCORF Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $304

Moomoo NewsDec 9 08:33 ET

Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $290

Moomoo NewsDec 6 05:33 ET

Analysts' Top Healthcare Picks: Insulet (PODD), Monte Rosa Therapeutics (GLUE)

TipRanksDec 6 04:53 ET

Morgan Stanley Sticks to Their Buy Rating for Insulet (PODD)

TipRanksDec 5 10:23 ET

Leerink Partners Keeps Their Buy Rating on Insulet (PODD)

TipRanksNov 28 04:29 ET

CCORF Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $269

Moomoo NewsNov 21 07:34 ET

Insulet's Strategic Advancements and Market Positioning Drive Buy Rating

TipRanksNov 21 07:00 ET